GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $154 | -27.7% | 46,900 | -1.5% | 0.00% | – |
| Q2 2023 | $213 | +13.9% | 47,600 | +23.0% | 0.00% | – |
| Q1 2023 | $187 | +79.8% | 38,700 | +16.6% | 0.00% | – |
| Q4 2022 | $104 | -99.9% | 33,200 | -0.6% | 0.00% | – |
| Q3 2022 | $109,000 | -8.4% | 33,400 | +0.9% | 0.00% | – |
| Q2 2022 | $119,000 | – | 33,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 150,000 | $489,000 | 0.63% |
| CM Management, LLC | 125,000 | $408,000 | 0.46% |
| Greenlight Capital | 546,560 | $1,781,000 | 0.13% |
| Wealth Alliance Advisory Group, LLC | 25,000 | $82,000 | 0.04% |
| Cannell Capital | 12,371 | $40,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $189,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 40,000 | $130,000 | 0.00% |
| HOEY INVESTMENTS, INC | 500 | $2,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 87,967 | $286,000 | 0.00% |